The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice

Journal of Clinical Investigation

Volumn 121, Issue 6, 2011, Pages 2427-2435

  Bell, Christie L ^a   Vandenberghe, Luk H ^a   Bell, Peter ^a   Limberis, Maria P ^a   Gao, Guang Ping ^b   Van Vliet, Kim ^c   Agbandje McKenna, Mavis ^c   Wilson, James M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GALACTOSE; GLYCAN; LECTIN; SIALIC ACID; SIALIDASE;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 9; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING ASSAY; CELL MUTANT; CHO CELL; CONTROLLED STUDY; ENZYME DEFICIENCY; FEMALE; GENE TRANSFER; GLYCOPROTEIN SYNTHESIS; IN VIVO STUDY; LECTIN BINDING; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; VIRAL GENE DELIVERY SYSTEM; VIRUS ATTACHMENT; VIRUS ENTRY;

ANIMALS; CAPSID; CHO CELLS; CRICETINAE; CRICETULUS; DEPENDOVIRUS; DRUG DELIVERY SYSTEMS; GALACTOSE; GENE THERAPY; GENETIC VECTORS; GLYCOSYLATION; LUNG; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; NEURAMINIDASE; POLYSACCHARIDES; PROTEIN BINDING; RECEPTORS, VIRUS; TRANSDUCTION, GENETIC;

EID: 79957918498     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI57367     Document Type: Article

References (38)

1. Wu Z, Asokan A, Samulski RJ. Adeno-associated virus serotypes: vector toolkit for human gene therapy. Mol Ther. 2006;14(3):316-327. (Pubitemid 44184972)
2. Kern A, et al. Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J Virol. 2003;77(20):11072-11081. (Pubitemid 37204297)
3. Maguire AM, et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N Engl J Med. 2008;358(21):2240-2248. (Pubitemid 351724453)
4. Wu Z, Miller E, Agbandje-McKenna M, Samulski RJ. Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J Virol. 2006; 80(18):9093-9103. (Pubitemid 44359983)
5. Xiao W, Chirmule N, Berta SC, McCullough B, Gao G, Wilson JM. Gene therapy vectors based on adeno-associated virus type 1. J Virol. 1999;73(5):3994-4003. (Pubitemid 29189844)
6. Walters RW, et al. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem. 2001;276(23):20610- 20616.
7. Davidson BL, et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci U S A. 2000; 97(7):3428-3432. (Pubitemid 30183319)
8. Gao G, et al. Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc Natl Acad Sci U S A. 2003; 100(10):6081-6086. (Pubitemid 36576934)
9. Gao G, et al. Clades of Adeno-associated viruses are widely disseminated in human tissues. J Virol. 2004; 78(12):6381-6388. (Pubitemid 38715936)
10. Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci U S A. 2002;99(18):11854-11859. (Pubitemid 34994488)
11. Nam HJ, et al. Structure of adeno-associated virus serotype 8, a gene therapy vector. J Virol. 2007; 81(22):12260-12271.
12. Bish LT, et al. Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. Hum Gene Ther. 2008;19(12):1359-1368.
13. Duque S, et al. Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons. Mol Ther. 2009; 17(7):1187-1196.
14. Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol. 2009;27(1):59-65.
15. Limberis MP, Wilson JM. Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered. Proc Natl Acad Sci U S A. 2006;103(35):12993-12998. (Pubitemid 44338905)
16. Murray S, et al. Characterization of the capsid protein glycosylation of adeno-associated virus type 2 by high-resolution mass spectrometry. J Virol. 2006; 80(12):6171-6176. (Pubitemid 43849195)
17. Patnaik SK, Stanley P. Lectin-resistant CHO glycosylation mutants. Methods Enzymol. 2006;416:159-182. (Pubitemid 44750110)
18. Limberis MP, Vandenberghe LH, Zhang L, Pickles RJ, Wilson JM. Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. Mol Ther. 2009;17(2):294-301.
19. Inagaki K, et al. Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol Ther. 2006; 14(1):45-53. (Pubitemid 43899488)
20. Vandendriessche T, et al. Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy. J Thromb Haemost. 2007;5(1):16-24. (Pubitemid 44921062)
21. Cearley CN, Wolfe JH. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol Ther. 2006;13(3):528-537. (Pubitemid 43257620)
22. Zakhour M, et al. The alphaGal epitope of the histo-blood group antigen family is a ligand for bovine norovirus Newbury2 expected to prevent cross-species transmission. PLoS Pathog. 2009;5(7):e1000504.
23. Marth JD. O-Glycans. In: Varki A, Cummings R, Esko J, Freeze H, Hart G, Marth J, eds. Essentials of Glycobiology. Cold Spring Harbor, New York, USA: Cold Spring Harbor Laboratory Press; 1999:101-113.
24. Bergelson JM, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997;275(5304):1320-1323. (Pubitemid 27114163)
25. Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A. 1997;94(7):3352-3356. (Pubitemid 27157315)
26. Alemany R, Curiel DT. CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors. Gene Ther. 2001;8(17):1347-1353. (Pubitemid 32834304)
27. Smith T, et al. In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor. Mol Ther. 2002;5(6):770-779. (Pubitemid 34619070)
28. Martin K, Brie A, Saulnier P, Perricaudet M, Yeh P, Vigne E. Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism. Mol Ther. 2003;8(3):485-494. (Pubitemid 37161470)
29. Parker AL, et al. Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood. 2006; 108(8):2554-2561.
30. Shayakhmetov DM, Gaggar A, Ni S, Li ZY, Lieber A. Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J Virol. 2005; 79(12):7478-7491. (Pubitemid 40756784)
31. Waddington SN, et al. Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5. J Virol. 2007;81(17):9568-9571. (Pubitemid 47311502)
32. Wisse E, Jacobs F, Topal B, Frederik P, De Geest B. The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer. Gene Ther. 2008;15(17):1193-1199.
33. Shen S, Bryant KD, Brown SM, Randell SH, Asokan A. Terminal N-linked galactose is the primary receptor for adeno-associated virus 9 [published online ahead of print March 2, 2011]. J Biol Chem. doi:10.1074/jbc.M110.210922 jbc.M110.210922.
34. Kohlbrenner E, et al. Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system. Mol Ther. 2005;12(6):1217-1225. (Pubitemid 41723056)
35. Ng R, et al. Structural characterization of the dual glycan binding adeno-associated virus serotype 6. J Virol. 2010;84(24):12945-12957.
36. Mitchell M, et al. Production, purification and preliminary X-ray crystallographic studies of adenoassociated virus serotype 9. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009;65(pt 7):715-718.
37. Blixt O, et al. Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc Natl Acad Sci U S A. 2004;101(49):17033- 17038. (Pubitemid 39627769)
38. Bell P, et al. An optimized protocol for detection of E. coli beta-galactosidase in lung tissue following gene transfer. Histochem Cell Biol. 2005;124(1):77-85. (Pubitemid 41253165)